J.P. Morgan analysts said it was too early to discuss the financial impact of the recall, but estimated that $70 million to ...

Bausch + Lomb has reported a “voluntary recall” of certain intraocular lenses (IOLs) on its enVista platform due to ...

Bausch + Lomb has recalled its intraocular lenses after receiving reports of cases inflammation. The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular ...

Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of ...

NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bausch Lomb ...

Bausch + Lomb has initiated a voluntary recall of its enVista platform intraocular lenses (IOLs) following reports of TASS.

Eye health company Bausch + Lomb has issued a voluntary recall of a series of intraocular lenses, according to a March 27 ...

Bausch + Lomb (BLCO) announced a voluntary recall of intraocular lenses on its enVista platform. This action was taken out of an abundance of ...

Most cases of TASS can be treated with steroids within a few days, although severe cases can lead to permanent damage to the ...

Cataracts are one of the most common reasons for vision loss in adults, and they're also among the most misunderstood eye conditions.